• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Proove Bioscience

Pay no attention to the man behind the curtain with this company.

What a freak show proove is. When this house of cards falls I hope the crooks at the helm get buried. Just a matter of time, Karma is a bitch.....JMO
 




















Chief Science Officer left at 6 months right after he found out that the stats, science and tests were not able to match the sales and marketing. He had integrity and quit.

In-house general counsel quit after 6 working days.

C.C.O. and his right hand person quit after one week.

Rhonda (customer service) was fired.

The CEO's assistant nominates him for all the awards...

Tabore ( old head of research) use to comment how bogus the science was behind the tests to many..

The head of the lab quit a few months ago...

Shall I go on...
 




Chief Science Officer left at 6 months right after he found out that the stats, science and tests were not able to match the sales and marketing. He had integrity and quit.

In-house general counsel quit after 6 working days.

C.C.O. and his right hand person quit after one week.

Rhonda (customer service) was fired.

The CEO's assistant nominates him for all the awards...

Tabore ( old head of research) use to comment how bogus the science was behind the tests to many..

The head of the lab quit a few months ago...

Shall I go on...

Corporate is slimming down...

The Feds are cracking down on pain cream pharmacies, their docs, and reps!
They have busted these crooks in 48 states; it's going on as I type.

I hope Proove gets what they deserve next. When Feds start snooping, you're busted. This house of cards will soon fall. We are talking huge fines and jail time for all. Management down to reps. Karma is coming Brian and Joe.

My opinion is my opinion.
 




Quick question. Brian and Joe, how do you look in stripes?
Read it a weep boys. Sound familiar? Just asking.

Prosecutors said two pharmacies paid kickbacks to prescribing physicians in the form of "research fees." Another Florida pharmacy disguised $70,000 in kickbacks as speaker's fees for an Indiana physician. Marketing firms that steered TRICARE beneficiaries to compounding pharmacies received kickbacks as well, prosecutors said.

At least one physician receiving this tainted money has wound up as a felon. In June 2015, sports medicine specialist James Morales, MD, in Toms River, New Jersey, pleaded guilty to accepting $60,000 in cash bribes for referring pain cream scripts to a compounding pharmacy in nearby Lakewood, as well as falsifying health records. Dr Morales is scheduled to be sentenced in June. The president and pharmacist-in-charge of the pharmacy, Vladimir Kleyman, pleaded guilty to fraud charges and was sentenced to 20 months in prison.
 








Genetic testing laboratories have taken the place of the once-lucrative pain creams for some compounding pharmacies.

Most medical experts, however, question their effectiveness.

Look out Brian and Joe. Don't say we didn't warn you. The next scam you set up, try paying your distribution sales force. Karma won't bite you so hard.

We know your pockets are lined so maybe the stint in the slammer will be worth it.
My opinion is just that, my opinion.
 




Who does the following story remind you of? Except Proove pays $150 to physician per test, right?


Dr. Scott Wilson often participated in medical studies, so the one being proposed by the New Orleans laboratory Renaissance RX seemed reasonable.

An assistant would swab inside the cheeks of qualified patients and send the samples off to the company, which was doing research in the fast-growing arena of personalized genetic medicine.

Dr. Wilson signed on to what was supposed to be one of the largest and most definitive studies of its kind. In exchange, he and other doctors would be paid $75 for every patient they enrolled and tracked.

But Dr. Wilson left the study last year, saying the company pressured doctors to enroll patients regardless of whether they were eligible. In a lawsuit, he also accused the company of improper billing. Renaissance denies the accusations.

The story of Renaissance offers a view inside the intoxicating brew of hype and hope in the field of genetic testing. All over the country, labs and research firms are popping up, eager to study strands of DNA to better identify who is at risk for developing a disease, to guide existing treatments and to develop new ones. But the troubles at Renaissance speak volumes about how difficult it is for Medicare and private insurers to keep up with the proliferation of tests being offered.
 




From a recent patient....this says it all..

my pain management clinic has been pressuring me to undergo DNA testing "to see which medication is best for you when you develop a tolerance to this one" - which seems like a very stupid reason. The company is Proove, of course. I have done some reading and their testing is not done independently - they fund their own research. That's not at all objective. And the remark that it's "proven" that 50% of addiction is due to genetics is just actually opinion - opinion by people in the rehab field who buy into the disease model, and who make their profits from treating addicts (as a retired drug counselor, I am familiar with this field).

I don't want anyone testing my DNA, and I resent this attempt to pressure me into it. The physician's assistant who was trying to talk me into it got exasperated and said, "Why won't you do this? Medicare pays for it!" as if this was my only objection. He also couldn't tell me how it worked. The Proove rep just repeated the nonsense written above by the Proove person who replied to your blog post. THEY conduct the research, which is not an unbiased way to do this. It's not good science and I think to ask someone to have a test that is permanently on your medical record is shameful.
 




Proove Biosciences

OverviewOverview

15Reviews

11Salaries

8Interviews

4Benefits

2Jobs
Employee review for Proove Biosciences

Jun 6, 2016

"Dysfunctional company , stay away, they steal from insurance companies"


Former Employee - Anonymous Employee in Irvine, CA

Negative Outlook

CEO

I worked at Proove Biosciences full-time (More than a year)

Pros

They state they are the future of medicine and want to provide this valuable test for patients that need it. However, this is not the case they try to test everyone and it's a scam

Cons

The CEO of this company is arrogant and comes across like a used car salesman. The person in charge of sales is one of the sleaziest people you'll ever meet

Advice to Management

Get some morals, pay your sales team and pay your doctors
 




Who does the following story remind you of? Except Proove pays $150 to physician per test, right?


Dr. Scott Wilson often participated in medical studies, so the one being proposed by the New Orleans laboratory Renaissance RX seemed reasonable.

An assistant would swab inside the cheeks of qualified patients and send the samples off to the company, which was doing research in the fast-growing arena of personalized genetic medicine.

Dr. Wilson signed on to what was supposed to be one of the largest and most definitive studies of its kind. In exchange, he and other doctors would be paid $75 for every patient they enrolled and tracked.

But Dr. Wilson left the study last year, saying the company pressured doctors to enroll patients regardless of whether they were eligible. In a lawsuit, he also accused the company of improper billing. Renaissance denies the accusations.

The story of Renaissance offers a view inside the intoxicating brew of hype and hope in the field of genetic testing. All over the country, labs and research firms are popping up, eager to study strands of DNA to better identify who is at risk for developing a disease, to guide existing treatments and to develop new ones. But the troubles at Renaissance speak volumes about how difficult it is for Medicare and private insurers to keep up with the proliferation of tests being offered.
 




All managers in both buildings are a joke. Sit on their asses pretending to work. Funny how every single person knows how useless they are. This company is a total joke.....
 




All managers in both buildings are a joke. Sit on their asses pretending to work. Funny how every single person knows how useless they are. This company is a total joke.....

This company is one of many scamming insurance companies and our government.
No peer reviews, proprietary software that nobody can see, I bet their reports are bogus. Matter of time boys, matter of time.
JMHO
 




This company is one of many scamming insurance companies and our government.
No peer reviews, proprietary software that nobody can see, I bet their reports are bogus. Matter of time boys, matter of time.
JMHO

Bogus, can you say Bogus with a capital B?
Try to pull up a complete clinical outcome or peer review "study" on the proove website. It won't let you do it? Strangest research paper's I've ever "not" seen.
What are they hiding? Just asking....
 




It so unfortunate the way this company is. There are betters ones out there. Start looking fellas.... I quit this job because this company won't last long and because of very very and I mean very Stupid people I used to work with especially one in particular. What a bi*ch. We'll see who has the last laugh.....
 




It so unfortunate the way this company is. There are betters ones out there. Start looking fellas.... I quit this job because this company won't last long and because of very very and I mean very Stupid people I used to work with especially one in particular. What a bi*ch. We'll see who has the last laugh.....

Are you calling Joe a bitch? I agree! Fits the stupid label also.
Has proove started paying their reps and docs yet?
 




Who does the following story remind you of? Except Proove pays $150 to physician per test, right?


Dr. Scott Wilson often participated in medical studies, so the one being proposed by the New Orleans laboratory Renaissance RX seemed reasonable.

An assistant would swab inside the cheeks of qualified patients and send the samples off to the company, which was doing research in the fast-growing arena of personalized genetic medicine.

Dr. Wilson signed on to what was supposed to be one of the largest and most definitive studies of its kind. In exchange, he and other doctors would be paid $75 for every patient they enrolled and tracked.

But Dr. Wilson left the study last year, saying the company pressured doctors to enroll patients regardless of whether they were eligible. In a lawsuit, he also accused the company of improper billing. Renaissance denies the accusations.

The story of Renaissance offers a view inside the intoxicating brew of hype and hope in the field of genetic testing. All over the country, labs and research firms are popping up, eager to study strands of DNA to better identify who is at risk for developing a disease, to guide existing treatments and to develop new ones. But the troubles at Renaissance speak volumes about how difficult it is for Medicare and private insurers to keep up with the proliferation of tests being offered.